Millennium Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-60,000
Closed -$5.96M 4922
2019
Q3
$5.96M Hold
60,000
0.01% 1665
2019
Q2
$5.55M Sell
60,000
-72,500
-55% -$6.88M 0.01% 1687
2019
Q1
$12.5M Buy
132,500
+32,500
+33% +$2.84M 0.02% 1100
2018
Q4
$6.41M Buy
+100,000
New +$7.38M 0.01% 1414
2018
Q3
Sell
-320,000
Closed -$25.4M 4567
2018
Q2
$25.4M Buy
320,000
+220,000
+220% +$18.3M 0.03% 734
2018
Q1
$8.92M Buy
+100,000
New +$9.6M 0.01% 1414
2017
Q4
Sell
-100,000
Closed -$14.6M 4332
2017
Q3
$14.6M Hold
100,000
0.02% 975
2017
Q2
$13M Hold
100,000
0.02% 907
2017
Q1
$12.4M Sell
100,000
-125,000
-56% -$15M 0.02% 912
2016
Q4
$26M Sell
225,000
-25,000
-10% -$2.78M 0.05% 488
2016
Q3
$26.1M Buy
250,000
+150,000
+150% +$16.2M 0.04% 476
2016
Q2
$9.86M Buy
+100,000
New +$10.3M 0.02% 861
2015
Q1
Sell
-276,400
Closed -$30.9M 4574
2014
Q4
$30.9M Buy
276,400
+197,600
+251% +$20.8M 0.07% 409
2014
Q3
$7.47M Sell
78,800
-10,200
-11% -$920K 0.02% 1037
2014
Q2
$7.64M Buy
+89,000
New +$6.77M 0.02% 972
2014
Q1
Sell
-3,800
Closed -$321K 4309
2013
Q4
$321K Buy
+3,800
New +$301K ﹤0.01% 2995

Other funds holding CELG

Millennium Management's CELG Position: Q4 2019 in Review

Millennium Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,169,794 shares — an estimated $414M sold.

Millennium Management first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $414M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Millennium Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Millennium Management sold 4,169,794 Celgene Corp shares in Q4 2019, an estimated $414M.
  • Millennium Management first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Millennium Management's Celgene Corp position peaked at $414M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Millennium Management's 13F filing for Q4 2019, filed 14 Feb 2020.